Synthetic opioids

FILE - In this June 6, 2017 file photo, an example of the amount of fentanyl that can be deadly after a news conference about deaths from fentanyl exposure, at DEA Headquarters in Arlington Va. The Justice Department’s inspector general says the Drug Enforcement Administration was “slow to respond” as America grappled with a rising opioid epidemic. The watchdog released a report Tuesday examining the agency’s regulatory and enforcement efforts to control opioids. (AP Photo/Jacquelyn Martin, File)
October 01, 2019 - 2:35 pm
WASHINGTON (AP) — The Drug Enforcement Administration was "slow to respond" as America grappled with a rising opioid epidemic, the Justice Department's inspector general said in a report Tuesday that faulted the agency for cutting back use of a key enforcement tool and continuing to raise...
Read More
FILE - In this Oct. 2, 2016 file photo, Mac Miller performs at the 2016 The Meadows Music and Arts Festivals at Citi Field in Flushing, New York. Authorities say an Arizona man has become the second person arrested on drug charges in the investigation of the overdose death of the rapper. Havasu City, Ariz., police said Tuesday, Sept. 24, 2019, that Ryan Reavis has been charged with possession of marijuana and prescription drugs. (Photo by Scott Roth/Invision/AP, File)
September 25, 2019 - 3:41 pm
LOS ANGELES (AP) — An Arizona man has become the second person arrested on drug charges in the investigation of the overdose death of rapper Mac Miller, authorities said. Ryan Reavis, 36, was charged in Mohave County court with possession of marijuana, prescription drugs and drug paraphernalia;...
Read More
Moussa81 iStock / Getty Images Plus
Associated Press
September 25, 2019 - 12:54 pm
A new analysis finds that money from a tentative settlement with OxyContin maker Purdue Pharma will be "no more than a stopgap" for state and local governments struggling to combat the opioid epidemic. Purdue became the first company being sued over the toll of opioids to reach a tentative...
Read More
FILE - In this Thursday, Sept. 12, 2019 file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. The allegations surrounding wealthy donors such as the Sackler family have raised questions for the museums they supported, including whether to keep the family's name on prominent galleries. The billionaire family is notorious for its ties to the drug company Purdue Pharma, which developed OxyContin, a painkiller that has been at the center of the opioid crisis. (AP Photo/Frank Franklin II, File)
September 18, 2019 - 1:13 am
NEW YORK (AP) — Ask the CEO and president of the Metropolitan Museum of Art whether he's accepting money from the Sacklers, the billionaire dynasty notorious for its ties to the drug company Purdue Pharma, and the answer is somewhat complicated. For one thing, it depends on which Sackler. "There...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 17, 2019 - 3:49 pm
The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by ... selling more OxyContin. That would amount to blood money, in the opinion of some critics. And it's one reason two dozen states have rejected the deal. "The...
Read More
FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Purdue Pharma, the company which makes OxyContin and other drugs, filed court papers in New York on Sunday, Sept. 15, 2019, seeking Chapter 11 bankruptcy protection. (AP Photo/Toby Talbot, File)
Associated Press
September 16, 2019 - 5:11 pm
BOSTON (AP) — OxyContin maker Purdue Pharma has embarked on a multibillion-dollar plan to settle thousands of lawsuits over the nation's deadly opioid crisis by transforming itself in bankruptcy court into a sort of hybrid between a business and a charity. Whether the company can pull it off...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 15, 2019 - 11:34 pm
Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy in White Plains, New York, days after reaching a tentative settlement with many of the state and local governments suing it over the toll of opioids. The filing was anticipated before...
Read More
Cars pass Purdue Pharma headquarters Thursday, Sept. 12, 2019, in Stamford, Conn. For months, the judge overseeing national litigation over the opioids crisis urged all sides to reach a settlement that could end thousands of lawsuits filed by state and local governments. But the chaotic developments this week in the case against OxyContin maker Purdue Pharma underscore how difficult that goal is. (AP Photo/Frank Franklin II)
September 13, 2019 - 11:11 pm
NEW YORK (AP) — The family that owns OxyContin maker Purdue Pharma used Swiss and other hidden accounts to transfer $1 billion to themselves, New York's attorney general contends in court papers filed Friday. New York — asking a judge to enforce subpoenas of companies, banks and advisers to Purdue...
Read More
Map shows state party and decision over Purdue settlement terms; 2c x 3 inches; 96.3 mm x 76 mm;
September 13, 2019 - 10:20 pm
MINNEAPOLIS (AP) — The opioid crisis has hit virtually every pocket of the U.S., from rural towns in deeply conservative states to big cities in liberal-leaning ones. But a curious divide has opened up. The nation's Republican state attorneys general have, for the most part, lined up in support of...
Read More
FILE - This May 8, 2007, file photo shows the Purdue Pharma logo at its offices in Stamford, Conn. It’s not entirely clear what a bankruptcy filing for Purdue Pharma would mean for the wealth of the Sackler family behind the business. Depending on how various legal actions proceed, the billionaire family could be on the hook for much more than outlined in the settlement. (AP Photo/Douglas Healey, File)
September 12, 2019 - 10:03 pm
Purdue Pharma could be heading for bankruptcy but the extent to which it would affect the Sackler family fortunes remains unclear. The company, which makes OxyContin and other drugs, this week reached a tentative agreement with thousands of local governments and more than 20 states over its role in...
Read More

Pages